LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of digital health solutions, announced today the formation of a joint venture with Saint Alphonsus Health System through the acquisition of a majority equity position in Intermountain Medical Imaging, LLC, the owner of five outpatient multi-modality imaging centers in Boise, Idaho. The Idaho-based joint venture ...

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2026 Results Conference Call Event Dat ...

SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release first quarter 2026 financial results on Thursday, May 14, 2026, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update. I ...

Financial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic* increased 4%, excluding revenue from divested product line GAAP operating margin of 11.6%, compared to 11.5% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.3% in prior year periodGAAP EPS $0.68, up 39%Non-GAAP EPS* $0.94, up 9%Free cash flow* generation of $24.7 million, up 26% Business Dev ...

Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billionOrganic net sales increased 2.4%Reported operating income margin of 15.5%Adjusted operating income margin(1) contracted 180 bps to 21.1%Reported EPS increased 14.2% to $1.93 Adjusted EPS(1) decreased 8.5% to $2.60 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Ac ...

公司核心事件 - Terrestrial Energy 公司将于2026年5月14日美股市场开盘前，发布2026年第一季度财报 [1] - 财报电话会议定于美国东部时间2026年5月14日上午8:30举行，首席执行官Simon Irish和首席财务官Brian Thrasher将出席 [1] - 会议将通过指定网址进行网络直播，并提供回放，财报新闻稿及演示文稿也将发布在公司投资者关系网站 [1] 公司技术与产品 - 公司是第四代小型模块化核电站开发商，核心技术为专有的“一体化熔盐反应堆”（IMSR） [2] - IMSR技术结合了熔盐反应堆的变革性运行优势，在资本效率、成本降低、多功能性方面具有创新设计 [2] - IMSR电站设计为小型模块化，用于分布式供应低成本、可靠、可调度、清洁的高温工业热能和电力 [2] - 该设计可针对双重能源用途进行定制，适用于石化与化学合成、数据中心运营等多种工业应用 [2] - IMSR电站的应用将核能扩展至远超电力市场的范围，支持清洁稳定热电的快速增长 [2] 公司战略与进展 - 公司采用创新工厂设计，结合经过验证的熔盐反应堆技术和易于获取的低浓铀燃料，具备独特的运行特性和商业潜力 [2] - 公司正与监管机构、供应商、工业伙伴及能源终端用户合作，目标是在2030年代初期建造、许可并投运首批IMSR电站 [2]

SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s first quarter 2026 financial results on Thursday, May 7, 2026, after the close of the U.S. financial markets. About Aligos Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biopharmaceutical company founded ...

核心观点 - 公司2026年第一季度整体业绩承压，净销售额同比下降6%至1.067亿美元，净亏损扩大至430万美元，但管理层对国际业务的强劲增长和公司整体势头感到满意，并宣布了每股0.25美元的季度股息 [1][3][5][7] 管理层评述与战略 - 管理层认为本季度非常成功，公司正在建立发展势头，持续关注国际增长的战略成效显著 [3] - 过去十二个月的国际净销售额达到1.38亿美元，为过去十年来的最高水平 [3] - 美国客户仍持谨慎态度，但公司正在重建去年被打乱的业务基础 [3] - 公司的服装业务在全球范围内持续稳步扩展其产品线广度和客户覆盖范围 [3] 2026年第一季度财务业绩总览 - **净销售额**：为1.067亿美元，同比下降6% [7] - **毛利率与毛利**：毛利率为33.4%，较2025年第一季度下降100个基点；毛利润为3560万美元，同比下降9% [7] - **营业亏损**：营业亏损为560万美元，而2025年第一季度亏损为380万美元 [7] - **净亏损**：归属于普通股股东的净亏损为430万美元，摊薄后每股亏损0.37美元，而2025年第一季度净亏损为240万美元，每股亏损0.21美元 [7] - **调整后业绩（非GAAP）**：调整后净亏损为190万美元，摊薄后每股亏损0.17美元；调整后息税折旧摊销前利润为负40万美元，而2025年第一季度为正40万美元 [7] 分地区销售表现 - **北美地区**：净销售额同比下降16%，但较2024年同期有所增长 [4] - **国际地区**：销售额为2900万美元，高于2025年同期的2100万美元和2024年同期的1630万美元 [4] - **具体区域增长**：欧洲销售额同比增长47.2%至1738万美元；澳大利亚与新西兰销售额同比增长302.8%至247万美元；亚洲销售额同比增长157.7%至194万美元 [27] 分业务线销售表现 - **动作游戏与收藏品**：净销售额为5530万美元，高于2025年同期的4290万美元和2024年同期的3300万美元 [4] - **玩具/消费品**：净销售额为1.001亿美元，同比下降7% [7] - **娃娃、角色扮演、装扮**：净销售额为3750万美元，而2025年和2024年同期分别为5550万美元和4060万美元 [4] - **服装**：净销售额为660万美元，同比增长13% [7] - **户外/季节性玩具**：净销售额为733万美元，同比下降19.4% [27] 资产负债表与现金流关键数据 - **库存**：截至2026年3月31日为5290万美元，略低于2025年同期的5320万美元和2025年12月31日的5980万美元 [5] - **现金**：截至2026年3月31日，现金及现金等价物与受限现金合计为6400万美元，高于2025年同期的5940万美元和2025年12月31日的5410万美元 [5] - **经营活动现金流**：2026年第一季度为2180万美元，而2025年第一季度为负170万美元 [17] - **应收账款周转天数**：为79天，高于2025年同期的76天 [17] - **存货周转天数**：为67天，高于2025年同期的64天 [17] 过去十二个月财务表现 - **过去十二个月调整后息税折旧摊销前利润**：为3460万美元，低于截至2025年第四季度的3540万美元 [7] - **过去十二个月国际净销售额**：达到1.38亿美元 [3] - **过去十二个月经营活动现金流**：为5000万美元 [17]

AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (“Swarmer”) (Nasdaq: SWMR), a drone autonomy software company which has supported more than 100,000 real-world combat missions in Ukraine since April 2024, will hold a conference call and webcast on Wednesday, May 13, 2026, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss its financial results for the quarter ended March 31, 2026. Financial results will be issued in a press release prior to the call. Swarmer management will host the ...

NASHVILLE, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2026. In addition, the Company announced an increased 2026 Normalized FFO guidance range of $1.59 to $1.65 per share (diluted), a $0.01 increase at the midpoint, and an increased Same Store Cash NOI growth guidance range of 3.75% to 4.75% (+25bps increase). FIRST QUARTER 2026 HIGHLIGHTS GAAP Net loss of $(0.00) per share, NAREIT FFO of $0.35 per sh ...